The European Health Emergency Response Authority (HERA) has issued recommendations to pharmaceutical companies to increase production of antibiotics used to treat respiratory infections ahead of winter in an effort to avoid a recurrence of shortages, especially of amoxicillin and amoxicillin/clavulanic acid. It also urged EU members not to hoard them at the expense of their general availability in Europe.

